Oncodesign Services

Oncodesign Services

Foundation date

05/01/1995

Sector

#Biotechnology - Therapeutics

Subsector

• #Therapeutics - Small molecules
• #R&D Services - CRO (Contract Research Organization)
• #R&D Services - Screening

Therapeutic areas

• #Digestive system
• #Diseases of the nervous system
• #Infectious and parasitic diseases
• #Neoplasms / cancer / oncology
• #Skin and subcutaneous tissue

Oncodesign is a biopharma company dedicated to the precision medicine. Oncodesign is able to predict and identify, at a very early stage, each molecule's therapeutic usefulness and potential to become an effective drug. Applied to kinase inhibitors, Oncodesign’s technology has already enabled the targeting of several promising molecules with substantial therapeutic potential, in oncology and elsewhere, along with partnerships with pharmaceutical groups such as Bristol-Myers Squibb and UCB.